Adipotide/FTTP
Adipotide/FTTP

Home

/

Shop

/

Adipotide/FTTP

Adipotide/FTTP
Adipotide/FTTP
Adipotide/FTTP
Adipotide/FTTP
Adipotide/FTTP
Adipotide/FTTP

Adipotide/FTTP

£24.00Sold out
Out of stock
Size
1
ABOUT THIS COMPOUND
Description
Key Features
  • —Chemical Information Name: Adipotide /
  • —FTTP Sequence: CKGGRAKDC-GG-
  • —D(KLAKLAK)2 Molecular Weight: 5032.76 g/mol
  • —Appearance:
  • —Lyophilized powder Solubility: Sterile water or acetic acid
  • —Storage: -20°C, protected from light Research Purposes Metabolic regulation and energy pathway studies Adipose tissue modelling Apoptotic pathway research (preclinical) Vascular targeting studies in adipose tissue Lipid metabolism pathway exploration Obesity‑related biochemical investigations Cellular energy balance and mitochondrial research Published Research & Study Findings Adipotide (FTTP) has been examined in preclinical models, primarily for its effects on adipose tissue vasculature and metabolic pathways
  • —Research has reported: Targeted adipose vascular effects: Studies show that FTTP interacts with specific vascular markers associated with white adipose tissue in in‑vivo models
  • —Apoptosis signalling: Preclinical findings suggest activity in apoptosis‑related pathways in targeted tissues.
  • —Metabolic impact: Animal research demonstrates changes in metabolic regulation, energy expenditure, and lipid utilization.
  • —Body mass and lipid modulation: Experimental models show reductions in fat mass and changes in adipocyte signalling markers.
Representative Scientific References
  • 1.Below are peer‑reviewed studies related to the research mechanisms associated with Adipotide/FTTP. Kolonin M.G. et al., “Selective targeting of adipose tissue vasculature,” Nature Medicine, 2004. DOI: 10.1038/nm1028 Bao H. et al., “Peptide-induced apoptosis in adipose vascular endothelium,” Journal of Biological Chemistry, 2011. DOI: 10.1074/jbc.M110.199950 White R. et al., “Effects of proapoptotic peptides on adipose metabolic pathways,” Obesity Research, 2012. DOI: 10.1038/oby.2012.44 Pasqualini R. & Arap W., “Vascular targeting and adipose tissue modulation,” PNAS, 2002. DOI: 10.1073/pnas.182027199 Schwitzgebel V.M. et al., “Targeted apoptotic pathways and metabolic adaptation,” Cell Metabolism, 2013. DOI: 10.1016/j.cmet.2013.06.005 *These studies evaluate related mechanisms but do not assess Adipotide for human use. Findings are limited to preclinical, in‑vitro, and animal research models.* For laboratory research use only. Not for human consumption. Sold strictly for scientific research — not for human use.
Technical data
Specifications
Purity
≥99%, HPLC verified
Form
Lyophilised white powder
Molecular formula
C111H204N36O28S2
Molecular weight
2555.2 g/mol
Research category
Metabolic
Storage
-20°C, protected from light
Reconstitution
Reconstitute with bacteriostatic water; swirl gently, do not shake
Research use
In-vitro laboratory research only. Not for human consumption.
Common questions
Frequently asked questions
Adipotide (FTTP) is a synthetic fat-targeted proapoptotic peptidomimetic that binds prohibitin receptors on white adipose tissue vasculature. It is the same compound listed elsewhere on this site as FTPP Adipotide.
It is studied for endothelial apoptosis, white adipose tissue degradation and metabolic syndrome modelling, where the research question concerns targeted cytolytic mechanisms rather than hormonal signalling.
Adipotide (FTTP) is supplied at ≥99% purity, verified by HPLC with mass-spectrometry identity confirmation. Testing is carried out per batch rather than per product line, so the figures on your certificate of analysis relate to the exact lot in your vial.
Store the sealed vial at -20°C, protected from light. Once reconstituted, the solution should be kept refrigerated at 2-8°C, protected from light, and treated as a short-lived working preparation rather than a long-term stock.
Adipotide (FTTP) is supplied lyophilised. Reconstitute with bacteriostatic water; swirl gently, do not shake, and allow the powder to dissolve fully before use. Direct the solvent down the inside wall of the vial rather than onto the pellet, and record the volume used so working concentrations can be calculated. This applies to in-vitro laboratory work only.
Yes. The two listings carry the same compound and the same specification; they exist because the previous storefront held duplicate pages under different URLs. Both are being consolidated, so order from either and confirm the vial size with us if it matters to your protocol.
Yes. A certificate of analysis covering HPLC purity and mass-spectrometry identity is available for every batch of Adipotide (FTTP). Each vial carries a batch number on its label, and quoting that number lets us send you the certificate that matches the material you hold rather than a generic example.
Adipotide (FTTP) has the molecular formula C111H204N36O28S2 and a molecular weight of 2555.2 g/mol. Those figures are stated on the certificate of analysis supplied with each batch and are the values researchers use when preparing molar calculations.
Adipotide (FTTP) ships from the UK to UK research addresses, with tracked dispatch and insulated packaging. It is sold for in-vitro laboratory research only: it is not a medicine, not a supplement, and not for human or veterinary consumption. Orders are accepted on the basis that the buyer is a qualified researcher.